Literature DB >> 7177580

Sequential development of the liver lesions in new-born lambs infected with Rift Valley fever virus. I. Macroscopic and microscopic pathology.

J A Coetzer, K G Ishak.   

Abstract

Ten new-born lambs were necropsied at various intervals after artificial infection with Rift Valley fever virus for the study of the sequential development of the hepatic lesions. During the late stage of the disease, the livers were slightly to moderately swollen and mottled yellow, orange-brown and red. Greyish-white foci, approximately 0,25-0,5 mm in diameter, were also scattered throughout the parenchyma. Microscopically, the liver lesions progressed from sparsely distributed acidophilic bodies and hepatocytes, revealing acidophilic degeneration and necrosis 6-12 h post-inoculation, to small randomly scattered primary foci of necrosis 12-24 h after infection. At 30-36 h, these primary foci were larger and more circumscribed. In addition, numerous acidophilic bodies and necrotic hepatocytes were dispersed throughout the markedly degenerated parenchyma. The terminal stage of the disease (48-53 h after inoculation), was characterized by massive hepatic necrosis in which primary foci of necrosis could still be recognized as dense aggregates of cytoplasmic and nuclear debris.

Entities:  

Mesh:

Year:  1982        PMID: 7177580

Source DB:  PubMed          Journal:  Onderstepoort J Vet Res        ISSN: 0030-2465            Impact factor:   1.792


  12 in total

1.  Inhibition of Rift Valley fever virus replication and perturbation of nucleocapsid-RNA interactions by suramin.

Authors:  Mary Ellenbecker; Jean-Marc Lanchy; J Stephen Lodmell
Journal:  Antimicrob Agents Chemother       Date:  2014-09-29       Impact factor: 5.191

2.  Pathologic studies on suspect animal and human cases of Rift Valley fever from an outbreak in Eastern Africa, 2006-2007.

Authors:  Wun-Ju Shieh; Chris D Paddock; Edith Lederman; Carol Y Rao; L Hannah Gould; Mohamed Mohamed; Fausta Mosha; Janeth Mghamba; Peter Bloland; M Kariuki Njenga; David Mutonga; Amwayi A Samuel; Jeannette Guarner; Robert F Breiman; Sherif R Zaki
Journal:  Am J Trop Med Hyg       Date:  2010-08       Impact factor: 2.345

3.  Development and characterization of monoclonal antibodies against Rift Valley fever virus nucleocapsid protein generated by DNA immunization.

Authors:  Raquel Martín-Folgar; Gema Lorenzo; Hani Boshra; Javier Iglesias; Francisco Mateos; Belén Borrego; Alejandro Brun
Journal:  MAbs       Date:  2010-05-02       Impact factor: 5.857

Review 4.  Rift Valley Fever.

Authors:  Amy Hartman
Journal:  Clin Lab Med       Date:  2017-03-22       Impact factor: 1.935

5.  Rift Valley fever virus(Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention.

Authors:  Michel Pepin; Michele Bouloy; Brian H Bird; Alan Kemp; Janusz Paweska
Journal:  Vet Res       Date:  2010 Nov-Dec       Impact factor: 3.683

6.  Tissue tropism and target cells of NSs-deleted rift valley fever virus in live immunodeficient mice.

Authors:  Céline Gommet; Agnès Billecocq; Grégory Jouvion; Milena Hasan; Tânia Zaverucha do Valle; Laurent Guillemot; Charlène Blanchet; Nico van Rooijen; Xavier Montagutelli; Michèle Bouloy; Jean-Jacques Panthier
Journal:  PLoS Negl Trop Dis       Date:  2011-12-06

7.  Neuropathological microscopic features of abortions induced by Bunyavirus / or Flavivirus infections.

Authors:  Javad Javanbakht; Seyed Hossein Mardjanmehr; Abbas Tavasoly; Mohammad Hossein Nazemshirazi
Journal:  Diagn Pathol       Date:  2014-11-26       Impact factor: 2.644

Review 8.  Potential of Using Capripoxvirus Vectored Vaccines Against Arboviruses in Sheep, Goats, and Cattle.

Authors:  Mahder Teffera; Shawn Babiuk
Journal:  Front Vet Sci       Date:  2019-12-20

9.  Pathological studies on postvaccinal reactions of Rift Valley fever in goats.

Authors:  Samia Ahmed Kamal
Journal:  Virol J       Date:  2009-07-06       Impact factor: 4.099

Review 10.  RNA Encapsidation and Packaging in the Phleboviruses.

Authors:  Katherine E Hornak; Jean-Marc Lanchy; J Stephen Lodmell
Journal:  Viruses       Date:  2016-07-15       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.